137 related articles for article (PubMed ID: 37969129)
1. Non-invasive biomarkers for identification of vanishing bile duct syndrome among children with acute cholestatic hepatitis.
Wang NL; Chen L; Lin J; Lu Y; Fang WY; Xie XB; Wang JS
Transl Pediatr; 2023 Oct; 12(10):1782-1790. PubMed ID: 37969129
[TBL] [Abstract][Full Text] [Related]
2. [Value of serum gamma-glutamyl transpeptidase combined with direct bilirubin in the diagnosis of biliary atresia in infants].
Fu HY; Zhao RQ; Bai GL; Yin CL; Yin RK; Li HH; Shi WN; Liu YL; Cheng LJ; Jia XY; Li GG; Zhao SG
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Dec; 21(12):1198-1202. PubMed ID: 31874659
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Serum Gamma Glutamyl Transpeptidase (GGT) for Early Diagnosis of Biliary Atresia.
Haque MA; Karim MB; Sultana K; Hasan MS; Hussain F; Musabbir N; Anwar SA
Mymensingh Med J; 2023 Jan; 32(1):193-199. PubMed ID: 36594320
[TBL] [Abstract][Full Text] [Related]
4. Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.
Cho HJ; Jwa HJ; Kim KS; Gang DY; Kim JY
Pediatr Gastroenterol Hepatol Nutr; 2013 Dec; 16(4):273-8. PubMed ID: 24511525
[TBL] [Abstract][Full Text] [Related]
5. Infliximab-Induced Vanishing Bile Duct Syndrome.
Eiswerth MJ; Heckroth MA; Ismail A; Gondim DD; Kaufman R
Cureus; 2022 Feb; 14(2):e21940. PubMed ID: 35273881
[TBL] [Abstract][Full Text] [Related]
6. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
[TBL] [Abstract][Full Text] [Related]
7. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
8. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
[TBL] [Abstract][Full Text] [Related]
9. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
10. Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection.
Yan LT; Wang LL; Yao J; Yang YT; Mao XR; Yue W; Mao YW; Zhou W; Chen QF; Chen Y; Duan ZP; Li JF
Medicine (Baltimore); 2020 Feb; 99(8):e19248. PubMed ID: 32080129
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.
Wu B; Zhou Y; Tian X; Cai W; Xiao Y
Eur J Pediatr; 2022 Nov; 181(11):3945-3953. PubMed ID: 36094664
[TBL] [Abstract][Full Text] [Related]
12. Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma.
Nano O; Ivanov S; Kapoor T
J Med Cases; 2023 May; 14(5):162-168. PubMed ID: 37303969
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
14. A Case of Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome.
Shionoya K; Kobayashi M; Kako M; Masuda S; Makazu M; Koizumi K
Intern Med; 2023 Nov; ():. PubMed ID: 37952956
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.
Mizuno F; Imai N; Yasuda K; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M; Kawashima H
Intern Med; 2024 Jan; 63(1):57-61. PubMed ID: 37164665
[TBL] [Abstract][Full Text] [Related]
16. [Response to Primary Biliary Cholangitis Treatment: Influencing Factors and the Role in Prognosis Prediction].
Liu Y; Fan X; Shen Y; Men R; Guo Y; Yang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):930-936. PubMed ID: 37866948
[TBL] [Abstract][Full Text] [Related]
17. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
Takaki Y; Murahashi M; Honda K; Hirai K
Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354
[TBL] [Abstract][Full Text] [Related]
18. Reversible vanishing bile duct syndrome induced by carbamazepine.
Ramos AM; Gayotto LC; Clemente CM; Mello ES; Luz KG; Freitas ML
Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1019-22. PubMed ID: 12352223
[TBL] [Abstract][Full Text] [Related]
19. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.
Zhao Z; Bao L; Yu X; Zhu C; Xu J; Wang Y; Yin M; Li Y; Li W
Medicine (Baltimore); 2017 Sep; 96(36):e8009. PubMed ID: 28885366
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
